Shopping Cart 0
Cart Subtotal
AED 0

Global Entyvio (vedolizumab) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn's disease.

Scope of the Report:

This report focuses on the Entyvio (vedolizumab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Entyvio (vedolizumab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Takeda

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Type 1

Type 2

Market Segment by Applications, can be divided into

Ulcerative Colitis

Crohn's Disease

There are 15 Chapters to deeply display the global Entyvio (vedolizumab) Drug market.

Chapter 1, to describe Entyvio (vedolizumab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Entyvio (vedolizumab) Drug, with sales, revenue, and price of Entyvio (vedolizumab) Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Entyvio (vedolizumab) Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Entyvio (vedolizumab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Entyvio (vedolizumab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Entyvio (vedolizumab) Drug Introduction

1.2 Market Analysis by Type

1.2.1 Type 1

1.2.2 Type 2

1.3 Market Analysis by Applications

1.3.1 Ulcerative Colitis

1.3.2 Crohn's Disease

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Takeda

2.1.1 Business Overview

2.1.2 Entyvio (vedolizumab) Drug Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Entyvio (vedolizumab) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017

3.3.2 Top 6 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Entyvio (vedolizumab) Drug Market Analysis by Regions

4.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Regions

4.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Regions (2013-2018)

4.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Regions (2013-2018)

4.2 North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.3 Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.5 South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5 North America Entyvio (vedolizumab) Drug by Countries

5.1 North America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

5.1.1 North America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

5.1.2 North America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

5.2 United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5.3 Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5.4 Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6 Europe Entyvio (vedolizumab) Drug by Countries

6.1 Europe Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

6.1.1 Europe Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

6.2 Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.3 UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.4 France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.5 Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.6 Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7 Asia-Pacific Entyvio (vedolizumab) Drug by Countries

7.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

7.2 China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.3 Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.4 Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.5 India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8 South America Entyvio (vedolizumab) Drug by Countries

8.1 South America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

8.1.1 South America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

8.1.2 South America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8.3 Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8.4 Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9 Middle East and Africa Entyvio (vedolizumab) Drug by Countries

9.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.3 UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.4 Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.5 Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.6 South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

10 Global Entyvio (vedolizumab) Drug Market Segment by Type

10.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Type (2013-2018)

10.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Type (2013-2018)

10.2 Type 1 Sales Growth and Price

10.2.1 Global Type 1 Sales Growth (2013-2018)

10.2.2 Global Type 1 Price (2013-2018)

10.3 Type 2 Sales Growth and Price

10.3.1 Global Type 2 Sales Growth (2013-2018)

10.3.2 Global Type 2 Price (2013-2018)

11 Global Entyvio (vedolizumab) Drug Market Segment by Application

11.1 Global Entyvio (vedolizumab) Drug Sales Market Share by Application (2013-2018)

11.2 Ulcerative Colitis Sales Growth (2013-2018)

11.3 Crohn's Disease Sales Growth (2013-2018)

12 Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)

12.2 Entyvio (vedolizumab) Drug Market Forecast by Regions (2018-2023)

12.2.1 North America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.2 Europe Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.3 Asia-Pacific Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.4 South America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.5 Middle East and Africa Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.3 Entyvio (vedolizumab) Drug Market Forecast by Type (2018-2023)

12.3.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)

12.3.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)

12.4 Entyvio (vedolizumab) Drug Market Forecast by Application (2018-2023)

12.4.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)

12.4.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Entyvio (vedolizumab) Drug Picture

Table Product Specifications of Entyvio (vedolizumab) Drug

Figure Global Sales Market Share of Entyvio (vedolizumab) Drug by Types in 2017

Table Entyvio (vedolizumab) Drug Types for Major Manufacturers

Figure Type 1 Picture

Figure Type 2 Picture

Figure Entyvio (vedolizumab) Drug Sales Market Share by Applications in 2017

Figure Ulcerative Colitis Picture

Figure Crohn's Disease Picture

Figure United States Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure France Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure UK Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure China Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure India Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Table Takeda Basic Information, Manufacturing Base and Competitors

Table Takeda Entyvio (vedolizumab) Drug Type and Applications

Table Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Entyvio (vedolizumab) Drug Sales by Manufacturer (2016-2017)

Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2016

Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2017

Table Global Entyvio (vedolizumab) Drug Revenue by Manufacturer (2016-2017)

Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2016

Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2017

Figure Top 3 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017

Figure Global Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Global Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales by Regions (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales Market Share by Regions (2013-2018)

Table Global Entyvio (vedolizumab) Drug Revenue by Regions (2013-2018)

Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2013

Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2017

Figure North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure North America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table North America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table North America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2013

Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017

Table North America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Table North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)

Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013

Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017

Figure United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Europe Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table Europe Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table Europe Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Table Europe Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2016

Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017

Figure Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries 2017

Table Asia-Pacific Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue Market Share by Countries 2017

Figure China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure South America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table South America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table South America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Figure South America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017

Table South America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Table South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)

Figure South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017

Figure Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017

Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013

Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017

Figure Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales by Type (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales Share by Type (2013-2018)

Table Global Entyvio (vedolizumab) Drug Revenue by Type (2013-2018)

Table Global Entyvio (vedolizumab) Drug Revenue Share by Type (2013-2018)

Figure Global Type 1 Sales Growth (2013-2018)

Figure Global Type 1 Price (2013-2018)

Figure Global Type 2 Sales Growth (2013-2018)

Figure Global Type 2 Price (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales by Application (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales Share by Application (2013-2018)

Figure Global Crohn's Disease Sales Growth (2013-2018)

Figure Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)

Table Global Entyvio (vedolizumab) Drug Sales Forecast by Regions (2018-2023)

Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Regions (2018-2023)

Figure North America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Figure Europe Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Figure Asia-Pacific Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Figure South America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Figure Middle East and Africa Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Table Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)

Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)

Table Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)

Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Takeda

Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn's disease.

Scope of the Report:

This report focuses on the Entyvio (vedolizumab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Entyvio (vedolizumab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Takeda

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Type 1

Type 2

Market Segment by Applications, can be divided into

Ulcerative Colitis

Crohn's Disease

There are 15 Chapters to deeply display the global Entyvio (vedolizumab) Drug market.

Chapter 1, to describe Entyvio (vedolizumab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Entyvio (vedolizumab) Drug, with sales, revenue, and price of Entyvio (vedolizumab) Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Entyvio (vedolizumab) Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Entyvio (vedolizumab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Entyvio (vedolizumab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Entyvio (vedolizumab) Drug Introduction

1.2 Market Analysis by Type

1.2.1 Type 1

1.2.2 Type 2

1.3 Market Analysis by Applications

1.3.1 Ulcerative Colitis

1.3.2 Crohn's Disease

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Takeda

2.1.1 Business Overview

2.1.2 Entyvio (vedolizumab) Drug Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Entyvio (vedolizumab) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017

3.3.2 Top 6 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Entyvio (vedolizumab) Drug Market Analysis by Regions

4.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Regions

4.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Regions (2013-2018)

4.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Regions (2013-2018)

4.2 North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.3 Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.5 South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5 North America Entyvio (vedolizumab) Drug by Countries

5.1 North America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

5.1.1 North America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

5.1.2 North America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

5.2 United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5.3 Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

5.4 Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6 Europe Entyvio (vedolizumab) Drug by Countries

6.1 Europe Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

6.1.1 Europe Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

6.2 Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.3 UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.4 France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.5 Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

6.6 Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7 Asia-Pacific Entyvio (vedolizumab) Drug by Countries

7.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

7.2 China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.3 Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.4 Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.5 India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8 South America Entyvio (vedolizumab) Drug by Countries

8.1 South America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

8.1.1 South America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

8.1.2 South America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8.3 Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

8.4 Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9 Middle East and Africa Entyvio (vedolizumab) Drug by Countries

9.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.3 UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.4 Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.5 Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

9.6 South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

10 Global Entyvio (vedolizumab) Drug Market Segment by Type

10.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Type (2013-2018)

10.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Type (2013-2018)

10.2 Type 1 Sales Growth and Price

10.2.1 Global Type 1 Sales Growth (2013-2018)

10.2.2 Global Type 1 Price (2013-2018)

10.3 Type 2 Sales Growth and Price

10.3.1 Global Type 2 Sales Growth (2013-2018)

10.3.2 Global Type 2 Price (2013-2018)

11 Global Entyvio (vedolizumab) Drug Market Segment by Application

11.1 Global Entyvio (vedolizumab) Drug Sales Market Share by Application (2013-2018)

11.2 Ulcerative Colitis Sales Growth (2013-2018)

11.3 Crohn's Disease Sales Growth (2013-2018)

12 Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)

12.2 Entyvio (vedolizumab) Drug Market Forecast by Regions (2018-2023)

12.2.1 North America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.2 Europe Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.3 Asia-Pacific Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.4 South America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.2.5 Middle East and Africa Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

12.3 Entyvio (vedolizumab) Drug Market Forecast by Type (2018-2023)

12.3.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)

12.3.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)

12.4 Entyvio (vedolizumab) Drug Market Forecast by Application (2018-2023)

12.4.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)

12.4.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Entyvio (vedolizumab) Drug Picture

Table Product Specifications of Entyvio (vedolizumab) Drug

Figure Global Sales Market Share of Entyvio (vedolizumab) Drug by Types in 2017

Table Entyvio (vedolizumab) Drug Types for Major Manufacturers

Figure Type 1 Picture

Figure Type 2 Picture

Figure Entyvio (vedolizumab) Drug Sales Market Share by Applications in 2017

Figure Ulcerative Colitis Picture

Figure Crohn's Disease Picture

Figure United States Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure France Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure UK Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure China Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure India Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)

Table Takeda Basic Information, Manufacturing Base and Competitors

Table Takeda Entyvio (vedolizumab) Drug Type and Applications

Table Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Entyvio (vedolizumab) Drug Sales by Manufacturer (2016-2017)

Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2016

Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2017

Table Global Entyvio (vedolizumab) Drug Revenue by Manufacturer (2016-2017)

Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2016

Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2017

Figure Top 3 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017

Figure Global Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Global Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales by Regions (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales Market Share by Regions (2013-2018)

Table Global Entyvio (vedolizumab) Drug Revenue by Regions (2013-2018)

Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2013

Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2017

Figure North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure North America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table North America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table North America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2013

Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017

Table North America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Table North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)

Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013

Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017

Figure United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Europe Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table Europe Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table Europe Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Table Europe Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2016

Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017

Figure Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries 2017

Table Asia-Pacific Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue Market Share by Countries 2017

Figure China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure South America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table South America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table South America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Figure South America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017

Table South America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Table South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)

Figure South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017

Figure Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)

Table Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017

Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)

Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013

Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017

Figure Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Figure South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales by Type (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales Share by Type (2013-2018)

Table Global Entyvio (vedolizumab) Drug Revenue by Type (2013-2018)

Table Global Entyvio (vedolizumab) Drug Revenue Share by Type (2013-2018)

Figure Global Type 1 Sales Growth (2013-2018)

Figure Global Type 1 Price (2013-2018)

Figure Global Type 2 Sales Growth (2013-2018)

Figure Global Type 2 Price (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales by Application (2013-2018)

Table Global Entyvio (vedolizumab) Drug Sales Share by Application (2013-2018)

Figure Global Crohn's Disease Sales Growth (2013-2018)

Figure Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)

Table Global Entyvio (vedolizumab) Drug Sales Forecast by Regions (2018-2023)

Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Regions (2018-2023)

Figure North America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Figure Europe Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Figure Asia-Pacific Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Figure South America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Figure Middle East and Africa Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)

Table Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)

Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)

Table Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)

Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Takeda